Page last updated: 2024-09-03

pramipexole and Addiction, Opioid

pramipexole has been researched along with Addiction, Opioid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Escalona, R; Laubenthal, CE; Welch, JE1
Escalona, R; Fawcett, J; Rush, AJ1
Caine, SB; Everitt, BJ; Koob, GF; Parsons, LH; Schwartz, JC; Sokoloff, P1

Other Studies

3 other study(ies) available for pramipexole and Addiction, Opioid

ArticleYear
Rapid Treatment of Anhedonia With Pramipexole as Adjunct to Buprenorphine in Opioid Use Disorder.
    The primary care companion for CNS disorders, 2023, 10-26, Volume: 25, Issue:5

    Topics: Anhedonia; Buprenorphine; Humans; Narcotic Antagonists; Opioid-Related Disorders; Pramipexole

2023
Pramipexole Augmentation of Buprenorphine Improves Pain and Depression in Opioid Use Disorder: A Case Report.
    The primary care companion for CNS disorders, 2020, Oct-15, Volume: 22, Issue:5

    Topics: Analgesics, Opioid; Buprenorphine; Depression; Humans; Opioid-Related Disorders; Pain; Pramipexole

2020
D3 receptor test in vitro predicts decreased cocaine self-administration in rats.
    Neuroreport, 1997, Jul-07, Volume: 8, Issue:9-10

    Topics: Animals; Benzopyrans; Benzothiazoles; Cocaine; Dopamine Agonists; Dopamine Antagonists; In Vitro Techniques; Male; Naphthalenes; Opioid-Related Disorders; Oxazines; Pramipexole; Pyrrolidines; Quinolines; Rats; Receptors, Dopamine D2; Receptors, Dopamine D3; Self Administration; Thiazoles

1997